glp 1 non diabetic GLP-1 Receptor Agonists as Treatment of Nondiabetic Ischemic Stroke: A Systematic Review and Meta-Analysis glp 1 for non diabetics

Standard semaglutide titration: Weeks 1-4: 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Week 13+: 1.7 mg or 2.4 mg weekly (target dose) Hashimoto's-adjusted approach: Weeks 1-6: 0.25 mg weekly (extended to allow thyroid monitoring at week 6) Weeks 7-12: 0.5 mg weekly (TSH check before increasing) Weeks 13-16: 1.0 mg weekly Week 17+: Assess whether higher doses are needed The extended timeline allows for thyroid function checks at each step, ensuring levothyroxine doses are adjusted proactively rather than reactively

5,6 It should be recognised that LEADER and Harmony Outcomes studied populations with different cardiovascular risk and therefore comparison of the results should be undertaken with caution

This study convincingly shows how metastatic routes may shape the propensity of cancer cells to succumb to ferroptosis depending on the differing microenvironment in lymph or blood

These concerns can have many causes, so provider evaluation is important

Revised 08/2019

What Impacts Blood Glucose Levels